FIELD: medicine.
SUBSTANCE: invention refers to a method of treating tuberculosis with multiple drug resistance characterised by prescribing a combination of six anti-tuberculosis preparations in the intensive phase of chemotherapy and five preparations - in the phase of the 20-month therapy continuation, wherein the intensive phase duration makes at least 8 months until obtaining four negative culture results every month in tuberculosis with multiple drug resistance and until obtaining two negative culture results in all other cases of tuberculosis with multiple drug resistance, the phase of the therapy continuation makes 12 months.
EFFECT: higher clinical effectiveness.
1 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORMATION OF SHORTENED REGIMENS OF CHEMOTHERAPY FOR RESPIRATORY TUBERCULOSIS WITH MULTIPLE AND EXTENSIVE DRUG RESISTANCE OF MBT IN OLDER CHILDREN AND ADOLESCENTS | 2020 |
|
RU2748957C1 |
| METHOD FOR FORMING A CHEMOTHERAPY REGIMEN FOR PRIMARY INTRATHORACIC TUBERCULOSIS IN CHILDREN FROM TUBERCULOSIS INFECTION CENTERS | 2018 |
|
RU2704816C1 |
| ANTITUBECULOUS-CAUSED MEDICAMENTOUS POLYNEUROPATHY APPROACH | 2007 |
|
RU2353360C2 |
| COMBINED THERAPY OF TUBERCULOSIS | 2009 |
|
RU2484819C2 |
| METHOD FOR TREATMENT OF PULMONARY TUBERCULOSIS MULTIPLE DRUG-RESISTANCE OF TUBERCULOSIS MYCOBACTERIA | 2018 |
|
RU2687743C1 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2011 |
|
RU2478389C2 |
| PULMONARY TUBERCULOSIS TREATMENT METHOD | 2002 |
|
RU2195313C1 |
| METHOD FOR SELECTING SHORTENED CHEMOTHERAPY REGIMENS FOR THE TREATMENT OF PULMONARY TUBERCULOSIS | 2022 |
|
RU2805496C1 |
| METHOD OF TREATING PATIENTS WITH PULMONARY TUBERCULOSIS COMBINED WITH DIABETES MELLITUS | 2023 |
|
RU2825182C1 |
| METHOD FOR TREATING HUMAN TUBERCULOSIS | 2002 |
|
RU2238091C2 |
